Phase 4Not yet recruitingINTERVENTIONAL
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
ClinicalTrials.gov · NCT07859137 · Registry updated: 2026-10-05
- Condition / research focus
- Morbid Obesity
- Sponsor
- General Committee of Teaching Hospitals and Institutes, Egypt
- Countries with listed sites
- Egypt
- Registry dates and results
- Start: 2026-10. Completion: 2028-11 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Semaglutide weekly injection (drug)
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- The surgical department of Medical Research Institute Hospital, Alexandria University
Alexandria, Egypt